Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1848 1
1873 1
1879 1
1958 1
1962 1
1963 1
1967 1
1968 2
1969 3
1970 2
1971 12
1972 3
1974 1
1975 1
1976 11
1977 13
1978 7
1979 4
1980 8
1981 5
1982 18
1983 25
1984 18
1985 20
1986 27
1987 23
1988 22
1989 16
1990 26
1991 10
1992 22
1993 27
1994 18
1995 28
1996 31
1997 49
1998 44
1999 55
2000 37
2001 34
2002 39
2003 45
2004 47
2005 56
2006 66
2007 86
2008 98
2009 94
2010 111
2011 119
2012 137
2013 166
2014 171
2015 187
2016 202
2017 192
2018 178
2019 203
2020 235
2021 273
2022 255
2023 228
2024 236
2025 132

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,694 results

Results by year

Filters applied: . Clear all
Page 1
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Haanen J, Obeid M, Spain L, Carbonnel F, Wang Y, Robert C, Lyon AR, Wick W, Kostine M, Peters S, Jordan K, Larkin J; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Haanen J, et al. Among authors: peters s. Ann Oncol. 2022 Dec;33(12):1217-1238. doi: 10.1016/j.annonc.2022.10.001. Epub 2022 Oct 18. Ann Oncol. 2022. PMID: 36270461 Free article. No abstract available.
Overcoming therapy resistance in EGFR-mutant lung cancer.
Passaro A, Jänne PA, Mok T, Peters S. Passaro A, et al. Among authors: peters s. Nat Cancer. 2021 Apr;2(4):377-391. doi: 10.1038/s43018-021-00195-8. Epub 2021 Apr 15. Nat Cancer. 2021. PMID: 35122001 Review.
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
Hellmann MD, Paz-Ares L, Bernabe Caro R, Zurawski B, Kim SW, Carcereny Costa E, Park K, Alexandru A, Lupinacci L, de la Mora Jimenez E, Sakai H, Albert I, Vergnenegre A, Peters S, Syrigos K, Barlesi F, Reck M, Borghaei H, Brahmer JR, O'Byrne KJ, Geese WJ, Bhagavatheeswaran P, Rabindran SK, Kasinathan RS, Nathan FE, Ramalingam SS. Hellmann MD, et al. Among authors: peters s. N Engl J Med. 2019 Nov 21;381(21):2020-2031. doi: 10.1056/NEJMoa1910231. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562796 Free article. Clinical Trial.
A neutrophil response linked to tumor control in immunotherapy.
Gungabeesoon J, Gort-Freitas NA, Kiss M, Bolli E, Messemaker M, Siwicki M, Hicham M, Bill R, Koch P, Cianciaruso C, Duval F, Pfirschke C, Mazzola M, Peters S, Homicsko K, Garris C, Weissleder R, Klein AM, Pittet MJ. Gungabeesoon J, et al. Among authors: peters s. Cell. 2023 Mar 30;186(7):1448-1464.e20. doi: 10.1016/j.cell.2023.02.032. Cell. 2023. PMID: 37001504 Free PMC article.
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Baas P, Scherpereel A, Nowak AK, Fujimoto N, Peters S, Tsao AS, Mansfield AS, Popat S, Jahan T, Antonia S, Oulkhouir Y, Bautista Y, Cornelissen R, Greillier L, Grossi F, Kowalski D, Rodríguez-Cid J, Aanur P, Oukessou A, Baudelet C, Zalcman G. Baas P, et al. Among authors: peters s. Lancet. 2021 Jan 30;397(10272):375-386. doi: 10.1016/S0140-6736(20)32714-8. Epub 2021 Jan 21. Lancet. 2021. PMID: 33485464 Clinical Trial.
Immunotherapy-based combinations in metastatic NSCLC.
Desai A, Peters S. Desai A, et al. Among authors: peters s. Cancer Treat Rev. 2023 May;116:102545. doi: 10.1016/j.ctrv.2023.102545. Epub 2023 Mar 27. Cancer Treat Rev. 2023. PMID: 37030062 Free article. Review.
Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders.
Saffouri GB, Shields-Cutler RR, Chen J, Yang Y, Lekatz HR, Hale VL, Cho JM, Battaglioli EJ, Bhattarai Y, Thompson KJ, Kalari KK, Behera G, Berry JC, Peters SA, Patel R, Schuetz AN, Faith JJ, Camilleri M, Sonnenburg JL, Farrugia G, Swann JR, Grover M, Knights D, Kashyap PC. Saffouri GB, et al. Among authors: peters sa. Nat Commun. 2019 May 1;10(1):2012. doi: 10.1038/s41467-019-09964-7. Nat Commun. 2019. PMID: 31043597 Free PMC article. Clinical Trial.
Hemochromatosis.
Peters S. Peters S. JAAPA. 2023 Oct 1;36(10):41-42. doi: 10.1097/01.JAA.0000977708.62318.43. JAAPA. 2023. PMID: 37751257 No abstract available.
3,694 results